Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee endorsed fall flu vaccinations Thursday for just ...

South Africa has reported the highly pathogenic H5N1 strain of avian influenza, or bird flu, on two poultry farms in the ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Highly pathogenic avian influenza is having a deadly effect on Michigan’s eagle population. A 2022 outbreak reduced breeding ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.